Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2022

Jan 4, 2022

32044_dirs_2022-01-04_3119f987-1acd-41bf-ab6c-b65770995159.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-01-02

Reporting Person: Sabzevari Helen (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-01-02 Common Stock M 9765 Acquired 727291 Direct
2022-01-03 Common Stock S 3848 $3.6701 Disposed 723443 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-01-02 Restricted Stock Units $ M 9765 Disposed Common Stock (9765) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.

F3: The RSUs were granted on January 2, 2018 and have vested in full.